Monday, April 12, 2021 9:58:34 AM
There is also the possibility that MZ's patents will be grouped in suites according to patents and IP fields with separate public companies. Why isn't a connection being made now to boost the EGYF price to get the funding for Virosense instead of Virosense getting cloud/private placement funding?
If there will be a merging, why isn't the funding of Virosense being offered now to EGYF shareholders directly?
I want to see current price rising in EGYF based on fact so that a strong price base is built that will keep growing. These kinds of speculations create unsustainable prices and large drops, even if the future ends of fulfilling the speculation. Too long of a time period without information on the speculation creates weakness. EGYF has great IP and proven products even if more is not added. I will be a holder however the future unfolds. I do value as much stability as possible in the emerging process of a potentially disruptive technology.
Green Trades here to you and all of us.
There is excitement and I am glad to see dead money become fruitful after many years of being dead.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM